Page 559 - Williams Hematology ( PDFDrive )
P. 559

534            Part VI:  The Erythrocyte                                                                                                                           Chapter 35:  Aplastic Anemia: Acquired and Inherited            535




                 68.  Powers D: Aplastic anemia secondary to glue sniffing. N Engl J Med 273:700, 1965.    103. Dincol G, Saka B, Aktan M, et al: Very severe aplastic anemia following resection of
                 69.  Kirtadze I, Zurabashvili D: Study of chemical composition of glue “RAZI” used by sol-  lymphocytic thymoma: Effectiveness of antilymphocyte globulin, cyclosporine A and
                  vent abusers in Tbilisi. Georgian Med News 133:65, 2006.  granulocyte-colony stimulating factor. Am J Hematol 64:78, 2000.
                 70.  Sabbioni G, Sepai O, Norppa H, et al: Comparison of biomarkers in workers exposed to     104. Ritchie DS, Underhill C, Grigg AP. Aplastic anemia as a late complication of thymoma
                  2,4,6-trinitrotoluene. Biomarkers 12:21, 2007.         in remission. Eur J Haematol 68:389, 2002.
                 71.  Crawford MAD: Aplastic anaemia due to trinitrotoluene intoxication. Br Med J 2:430,     105. Gaglia A,  Bobota A,  Pectasides  E,  et  al: Successful  treatment  with  cyclosporine  of
                  1954.                                                  thymoma-related aplastic anemia. Anticancer Res 27:3025, 2007.
                 72.  Ajlouni K, Doeblin TD: The syndrome of hepatitis and aplastic anaemia. Br J Haematol     106. Trisal V, Nademanee A, Lau SK, Grannis FW Jr: Thymoma-associated severe aplastic
                  27:345, 1974.                                          anemia treated with surgical resection followed by allogeneic stem-cell transplantation.
                 73.  Hagler L, Pastore RA, Bergin JJ: Aplastic anemia following viral hepatitis: Report of 2   J Clin Oncol 25:3374, 2007.
                  fatal cases and literature review. Medicine (Baltimore) 54:139, 1975.    107. Arcasoy MO, Gockerman JP: Aplastic anaemia as an autoimmune complication of thy-
                 74.  Pol S, Driss F, Devergie A, et al: Is hepatitis C virus involved in hepatitis-associated   moma. Br J Haematol 137:272, 2007.
                  aplastic anemia? Ann Intern Med 113:435, 1990.        108. Park CY, Kim HJ, Kim YJ, et al: Very severe aplastic anemia appearing after thymec-
                 75.  Hibbs JR, Frickhofen N, Rosenfeld SJ, et al: Aplastic anemia and viral hepatitis: Non-A,   tomy. Korean J Intern Med 18:61, 2003.
                  non-B, non-C? JAMA 267:2051, 1992.                    109. Abrams EM, Gibson IW, Blydt-Hansen TD: The concurrent presentation of minimal
                 76.  Honkaniemi E, Gustafsson B, Fischler B, et al: Acquired aplastic anaemia in seven chil-  change nephrotic syndrome and aplastic anemia. Pediatr Nephrol 24:407, 2009.
                  dren with severe hepatitis with or without liver failure. Acta Paediatr 96:1660, 2007.    110. Aitchison RGM, Marsh JCW, Hows JM, et al: Pregnancy associated aplastic anaemia:
                 77.  Tzakis AG, Arditi M, Whitington PF, et al: Aplastic anemia complicating orthotopic   A report of 5 cases and review of current management. Br J Haematol 73:541, 1989.
                  liver transplantation for non-A, non-B hepatitis. N Engl J Med 319:393, 1988.    111. Pajor A, Kelemen E, Szak’acs Z, Lehoczky D: Pregnancy in idiopathic aplastic anemia
                 78.  Brown KE, Tisdale J, Barrett AJ, Dunbar CE, Young NS: Hepatitis-associated aplastic   (report of 10 patients). Eur J Obstet Gynecol Reprod Biol 45:19, 1992.
                  anemia. N Engl J Med 336:1059, 1997.                  112. Bourantas K, Makrydimas G, Georgiou I, et al: Aplastic anemia: Report of a case with
                 79.  Safadi R, Or R, Ilan Y, et al: Lack of known hepatitis virus in hepatitis-associated aplas-  recurrent episodes in consecutive pregnancies. J Reprod Med 42:672, 1997.
                  tic anemia and outcome after bone marrow transplantation. Bone Marrow Transplant     113. Kwon JY, Lee Y, Shin JC, et al: Supportive management of pregnancy-associated aplastic
                  27:183, 2001.                                          anemia. Int J Gynaecol Obstet 95:115, 2006.
                 80.  Mishra B, Malhotra P, Ratho RK, et al: Human parvovirus B19 in patients with aplastic     114. Thakral B, Saluja K, Sharma RR, et al: Successful management of pregnancy-associated
                  anemia. Am J Hematol 79:166, 2005.                     severe aplastic anemia. Eur J Obstet Gynecol Reprod Biol 131:244, 2007.
                 81.  Yetgin S, Cetin M, Ozyürek E, et al: Parvovirus B19 infection associated with severe     115. Tichelli A, Socie G, Marsh J, et al: Outcome of pregnancy and disease course among
                  aplastic anemia in an immunocompetent patient. Pediatr Hematol Oncol 21:223, 2004.  women with aplastic anemia treated with immunosuppression.  Ann Intern Med
                 82.  Wong S, Young NS, Brown KE: Prevalence of parvovirus B19 in liver tissue: No asso-  137:164, 2002.
                  ciation with fulminant hepatitis or hepatitis-associated aplastic anemia.  J Infect Dis     116. Court-Brown WM, Doll R: Leukaemia and aplastic anaemia in patients irradiated for
                  187:1581, 2003.                                        ankylosing spondylitis. 1957. J Radiol Prot 27:B15-B154, 2007.
                 83.  Locasciulli A, Bacigalupo A, Bruno B, et al: Hepatitis-associated aplastic anaemia: Epi-    117. Darby SC, Doll R, Gill SK, Smith PG: Long term mortality after a single treatment
                  demiology and treatment results obtained in Europe. A report of The EBMT aplastic   course with x-rays in patients treated with ankylosing spondylitis. Br J Cancer 55:179,
                  anaemia working party. Br J Haematol 149:890, 2010.    1987.
                 84.  Rauff B, Idrees M, Shah SAR, et al: Hepatitis associated aplastic anemia: A review. Virol     118. Johnson SAN, Bateman CJT, Beard MEJ, et al: Long-term haematological complica-
                  J 8: 87, 2011.                                         tions of Thorotrast. Q J Med 182:259, 1977.
                 85.  Lazarus KH, Baehner RL: Aplastic anemia complicating infectious mononucleosis: A     119. Martland HS: The occurrence of malignancy in radioactive persons: A general review
                  case report and review of the literature. Pediatrics 67:907, 1981.  of data gathered in the study of the radium dial painters, with special reference to the
                 86.  Baranski B, Armstrong G, Truman JT, et al: Epstein-Barr virus in the bone marrow of   occurrence of osteogeneic sarcoma and the inter-relationship of certain blood diseases.
                  patients with aplastic anemia. Ann Intern Med 109:695, 1988.  Am J Cancer 15:2435, 1931.
                 87.  Vinters HV, Mah V, Mohrmann R, Wiley CA: Evidence for human immunodeficiency     120. Cronkite EP, Haley TJ: Clinical aspects of acute radiation injury, in Manual on Radia-
                  virus (HIV) infection of the brain in a patient with aplastic anemia. Acta Neuropathol   tion Haematology, pp 169–173. International Atomic Energy Agency, Vienna, 1971.
                  76:311, 1988.                                         121. Mettler FA Jr, Moseley RD Jr: Medical Effects of Ionizing Irradiation, pp 1–185. Grune
                 88.  Samuel D, Castaing D, Adam R, et al: Fatal acute HIV infection with aplastic anaemia,   and Stratton, New York, 1985.
                  transmitted by liver graft. Lancet 1:1221, 1988.      122. Gale RP: USSR: Follow-up after Chernobyl. Lancet 1:401, 1990.
                 89.  Morales CE, Sriram I, Baumann MA: Myelodysplastic syndrome occurring as possible     123. Nimer SD, Leung DHY, Wolin MJ, Golde DW: Serum stem cell factor levels in patients
                  first manifestation of human immunodeficiency virus infection with subsequent pro-  with aplastic anemia. Int J Hematol 60:185, 1994.
                  gression to aplastic anaemia. Int J STD AIDS 1:55, 1990.    124. Kojima S, Matsuyama T, Kodera Y: Plasma levels and production of soluble stem cell
                 90.  Rosenfeld CS, Rybka WB, Weinbaum D, et al: Late graft failure due to dual bone mar-  factor by marrow stromal cells in patients with aplastic anaemia. Br J Haematol 99:440,
                  row infection with variants A and B of human Herpesvirus-6. Exp Hematol 23:626,   1997.
                  1995.                                                 125. Lyman SD, Seaberg M, Hanna R, et al: Plasma/serum levels of flt3 ligand are low in
                 91.  Pavithran K, Raji NL, Thomas M: Aplastic anemia complicating lupus erythematosus—  normal individuals and highly elevated in patients with Fanconi anemia and acquired
                  Report of a case and review of the literature. Rheumatol Int 22:253, 2002.  aplastic anemia. Blood 86:4091, 1995.
                 92.  Bailey FA, Lilly M, Bertoli LF, Ball GV: An antibody that inhibits in vitro bone mar-    126. Kojima S, Matsuyama T, Kodera Y, et al: Measurement of endogenous plasma granulo-
                  row proliferation in a patient with systemic lupus erythematosus and aplastic anemia.   cyte colony-stimulating factor in patients with acquired aplastic anemia by a sensitive
                  Arthritis Rheum 31:901, 1989.                          chemiluminescent immunoassay. Blood 87:1303, 1996.
                 93.  Roffe C, Cahill MR, Samanta A, et al: Aplastic anaemia in systemic lupus erythemato-    127. Kojima S, Matsuyama T, Kodera Y: Circulating erythropoietin in patients with acquired
                  sus: A cellular immune mechanism? Br J Rheumatol 30:301, 1991.  aplastic anaemia. Acta Haematol 94:117, 1995.
                 94.  Sumimoto S, Kawai M, Kasajima Y, Hamamoto T: Aplastic anemia associated with sys-    128. Emmons RVD, Reid DM, Cohen RL, et al: Human thrombopoietin levels are high when
                  temic lupus erythematosus. Am J Hematol 38:329, 1991.  thrombocytopenia is due to megakaryocyte deficiency and low when due to increased
                 95.  Winkler A, Jackson RW, Kay DS, et al: High-dose intravenous cyclophosphamide treat-  platelet destruction. Blood 87:4068, 1996.
                  ment of systemic lupus erythematosus-associated aplastic anemia [letter].  Arthritis     129. Nakao S, Matsushima K, Young N: Deficient interleukin I production by aplastic
                  Rheum 31:693, 1988.                                    anaemia monocytes. Br J Haematol 71:431, 1989.
                 96.  Kim SW, Rice L, Champlin R, Udden MM: Aplastic Anemia in eosinophilic fasciitis:     130. Holmberg LA, Seidel K, Leisenring W, Torok-Storb B: Aplastic anemia: Analysis of stro-
                  Responses to immunosuppression and marrow transplantation. Haematologica 28:131,   mal cell function in long-term marrow cultures. Blood 84:3685, 1994.
                  1997.                                                 131. Stute N, Fehse B, Schroder J, et al: Human mesenchymal stem cells are not of donor ori-
                 97.  Debusscher L, Bitar N, DeMaubeuge J, et al: Eosinophilic fasciitis and severe aplastic   gin in patients with severe aplastic anemia who underwent sex-mismatched allogeneic
                  anemia: Favorable response to either antithymocyte globulin or cyclosporin A in blood   bone marrow transplant. J Hematother Stem Cell Res 11:977, 2002.
                  and skin disorders. Transplant Proc 20:310, 1988.     132. Applebaum FR, Barrall J, Storb R, et al: Clonal cytogenetic abnormalities in patients
                 98.  Kumar  M,  Goldman  J:  Severe  aplastic  anemia  and  Grave’s  disease  in  a  paediatric   with otherwise typical aplastic anemia. Exp Hematol 15:1134, 1987.
                  patient. Br J Haematol 118:327, 2002.               132a. Kulasekararaj AG, Jiang J, Smith AE, et al: Somatic mutations identify a subgroup of
                 99.  Tomonari A, Tojo A, Iseki T, et al: Severe aplastic anemia with autoimmune thyroidi-  aplastic anemia patients who progress to myelodysplastic syndrome. Blood 124:2698,
                  tis showing no hematological response to intensive immunosuppressive therapy. Acta   2014.
                  Haematol 109:90, 2003.                                133. Negendank W, Weissman D, Bey TM, et al: Evidence for clonal disease by magnetic
                 100. Aydin Y, Berker D, Ustün I, et al: A very rare cause of aplastic anemia: Graves disease.   resonance imaging in patients with hypoplastic marrow disorders.  Blood 78:2872,
                  South Med J 101:666, 2008.                             1991.
                 101. Lima CS, Zantut Wittmann DE, Castro V, et al: Pancytopenia in untreated patients with     134. Schrezenmeier H, Hertenstein B, Wagner B, et al: A pathogenetic link between aplastic
                  Graves’ disease. Thyroid 16:403, 2006.                 anemia and paroxysmal nocturnal hemoglobinuria is suggested by a high frequency
                 102. Das PK, Wherrett D, Dror Y: Remission of aplastic anemia induced by treatment for   of aplastic anemia patients with a deficiency of phosphatidylinositol glycan anchored
                  Graves disease in a pediatric patient. Pediatr Blood Cancer 49:210, 2007.  proteins. Exp Hematol 23:81, 1995.







          Kaushansky_chapter 35_p0513-0538.indd   534                                                                   9/19/15   12:24 AM
   554   555   556   557   558   559   560   561   562   563   564